sb 203580 has been researched along with bupivacaine in 2 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (bupivacaine) | Trials (bupivacaine) | Recent Studies (post-2010) (bupivacaine) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 12,968 | 4,843 | 3,530 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Colvin, HP; Gerner, P; Haller, I; Klimaschewski, L; Lang, L; Lirk, P; Tomaselli, B | 1 |
Lei, HY; Lu, J; Xu, R; Xu, SY; Zhang, QG | 1 |
2 other study(ies) available for sb 203580 and bupivacaine
Article | Year |
---|---|
In vitro, inhibition of mitogen-activated protein kinase pathways protects against bupivacaine- and ropivacaine-induced neurotoxicity.
Topics: Amides; Anesthetics, Local; Animals; Anthracenes; Bupivacaine; Butadienes; Cell Size; Cell Survival; Cells, Cultured; Cytoprotection; Dose-Response Relationship, Drug; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Ganglia, Spinal; Imidazoles; JNK Mitogen-Activated Protein Kinases; Lidocaine; Membrane Potentials; Mitogen-Activated Protein Kinases; Neurons, Afferent; Nitriles; p38 Mitogen-Activated Protein Kinases; Phenotype; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Ropivacaine; Sodium Channels | 2008 |
Bupivacaine induces apoptosis via mitochondria and p38 MAPK dependent pathways.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Anesthetics, Local; Animals; Apoptosis; Bisbenzimidazole; Bupivacaine; Cell Line; Chlorides; Gene Expression Regulation, Enzymologic; Imidazoles; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; p38 Mitogen-Activated Protein Kinases; Phosphoproteins; Pyridines; Reactive Oxygen Species | 2011 |